These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21866658)

  • 21. Effects of Qishen Yiqi Dripping Pills () in Reducing Myocardial Injury and Preserving Microvascular Function in Patients Undergoing Elective Percutaneous Coronary Intervention: A Pilot Randomized Study.
    He GX; Xie J; Jiang H; Tan W; Xu B
    Chin J Integr Med; 2018 Mar; 24(3):193-199. PubMed ID: 28470563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycogen phosphorylase isoenzyme BB, creatine kinase isoenzyme MB and troponin I for monitoring patients with percutaneous coronary intervention - a pilot study.
    Skitek M; Kranjec I; Jerin A
    Med Glas (Zenica); 2014 Feb; 11(1):13-8. PubMed ID: 24496335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of intensive atorvastatin therapy on periprocedural PDCD4 expression in CD4+ T lymphocytes of patients with unstable angina undergoing percutaneous coronary intervention.
    Su Q; Li L; Liu Y; Zhou Y; Wang J; Sun Y
    Cardiology; 2014; 127(3):169-75. PubMed ID: 24434439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of tirofiban plus clopidogrel versus clopidogrel plus provisional abciximab on biomarkers of myocardial necrosis in patients with non-ST-elevation acute coronary syndromes treated with early aggressive approach. Results of the CLOpidogrel, upstream TIrofiban, in cath Lab Downstream Abciximab (CLOTILDA) study.
    Leoncini M; Toso A; Maioli M; Bellandi F; Badia T; Politi A; De Servi S; Dabizzi RP
    Am Heart J; 2005 Sep; 150(3):401. PubMed ID: 16169315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome.
    Chang SM; Yazbek N; Lakkis NM
    Catheter Cardiovasc Interv; 2004 Jun; 62(2):193-7. PubMed ID: 15170709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.
    Balian V; Galli M; Marcassa C; Cecchin G; Child M; Barlocco F; Petrucci E; Filippini G; Michi R; Onofri M
    Circulation; 2006 Oct; 114(18):1948-54. PubMed ID: 17060382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
    Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
    Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
    Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
    Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intensive Atorvastatin Therapy Attenuates the Inflammatory Responses in Monocytes of Patients with Unstable Angina Undergoing Percutaneous Coronary Intervention via Peroxisome Proliferator-Activated Receptor γ Activation.
    Yang J; Liu C; Zhang L; Liu Y; Guo A; Shi H; Liu X; Cheng Y
    Inflammation; 2015 Aug; 38(4):1415-23. PubMed ID: 25604313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study.
    Woo JS; Kim W; Ha SJ; Kim JB; Kim SJ; Kim WS; Seon HJ; Kim KS
    Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2252-60. PubMed ID: 23868944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting a late positive serum troponin in initially troponin-negative patients with non-ST-elevation acute coronary syndrome: clinical predictors and validated risk score results from the TIMI IIIB and GUSTO IIA studies.
    Januzzi JL; Newby LK; Murphy SA; Pieper K; Antman EM; Morrow DA; Sabatine MS; Ohman EM; Cannon CP; Braunwald E
    Am Heart J; 2006 Feb; 151(2):360-6. PubMed ID: 16442899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of intracoronary injection with xuesaitong in treating post-PCI slow-reflow phenomenon in patients with ST-segment elevation myocardial infarction].
    Gan LJ; Zhang CH; Zhang M
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Apr; 30(4):348-51. PubMed ID: 20669666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Point-of-care assessment of platelet reactivity after clopidogrel to predict myonecrosis in patients undergoing percutaneous coronary intervention.
    Mangiacapra F; Barbato E; Patti G; Gatto L; Vizzi V; Ricottini E; D'Ambrosio A; Wijns W; Di Sciascio G
    JACC Cardiovasc Interv; 2010 Mar; 3(3):318-23. PubMed ID: 20298992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effect of salvia miltiorrhiza and Ligustrazine injection on the early myocardial damage of patients with severe burn].
    Ding LT; Zhu YG; Gu ZQ; Cai LL; Peng JL; Lü GZ
    Zhonghua Shao Shang Za Zhi; 2012 Jun; 28(3):170-2. PubMed ID: 22967970
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Intracoronary Adenosine on Myonecrosis in Patients with Unstable Angina Pectoris Undergoing Percutaneous Coronary Intervention.
    Kizilirmak F; Gunes HM; Demir GG; Gokdeniz T; Guler E; Cakal B; Omaygenç MO; Yılmaz F; Savur U; Barutcu I
    Cardiovasc Drugs Ther; 2015 Dec; 29(6):519-526. PubMed ID: 26631392
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Remote ischaemic postconditioning: does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial.
    Carrasco-Chinchilla F; Muñoz-García AJ; Domínguez-Franco A; Millán-Vázquez G; Guerrero-Molina A; Ortiz-García C; Enguix-Armada A; Alonso-Briales JH; Hernández-García JM; de Teresa-Galván E; Jiménez-Navarro MF
    Heart; 2013 Oct; 99(19):1431-7. PubMed ID: 23850844
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.
    Chen WH; Lee PY; Ng W; Tse HF; Lau CP
    J Am Coll Cardiol; 2004 Mar; 43(6):1122-6. PubMed ID: 15028378
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardioprotective effects of intracoronary adenosine in diabetic patients undergoing elective percutaneous coronary intervention.
    Shehata M
    Minerva Cardioangiol; 2014 Dec; 62(6):461-71. PubMed ID: 24699551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of two-day atorvastatin pretreatment on the incidence of periprocedural myocardial infarction following elective percutaneous coronary intervention: a single-center, prospective, and randomized study.
    Veselka J; Zemánek D; Hájek P; Malý M; Adlová R; Martinkovicová L; Tesar D
    Am J Cardiol; 2009 Sep; 104(5):630-3. PubMed ID: 19699335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.